These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 22513487)
41. Ketoconazole encapsulated in chitosan-gellan gum nanocomplexes exhibits prolonged antifungal activity. Kumar S; Kaur P; Bernela M; Rani R; Thakur R Int J Biol Macromol; 2016 Dec; 93(Pt A):988-994. PubMed ID: 27659003 [TBL] [Abstract][Full Text] [Related]
42. [The effect of polyamidoamine (PAMAM) dendrimers on the solubility and pharmacokinetics of breviscapine]. Lu JJ; Wu ZH; Ping QN Yao Xue Xue Bao; 2009 Feb; 44(2):197-202. PubMed ID: 19408693 [TBL] [Abstract][Full Text] [Related]
43. Determination of minumum inhibitory concentrations of Candida species isolated from vaginal swab specimens by using broth macrodilution and E-test. Birinci A; Saniç A; Durupinar B J Chemother; 2001 Feb; 13(1):43-6. PubMed ID: 11233799 [TBL] [Abstract][Full Text] [Related]
44. Dendrimer-based posaconazole nanoplatform for antifungal therapy. Tang S; Chen J; Cannon J; Cao Z; Baker JR; Wang SH Drug Deliv; 2021 Dec; 28(1):2150-2159. PubMed ID: 34617850 [TBL] [Abstract][Full Text] [Related]
45. Ocular pharmacokinetics of topically-applied ketoconazole solution containing hydroxypropyl beta-cyclodextrin to rabbits. Zhang J; Wang L; Gao C; Zhang L; Xia H J Ocul Pharmacol Ther; 2008 Oct; 24(5):501-6. PubMed ID: 18803444 [TBL] [Abstract][Full Text] [Related]
46. Peptide dendrimers as antifungal agents and carriers for potential antifungal agent-N Stolarska M; Gucwa K; Urbańczyk-Lipkowska Z; Andruszkiewicz R J Pept Sci; 2020 Jan; 26(1):e3226. PubMed ID: 31845463 [TBL] [Abstract][Full Text] [Related]
47. Polyamidomine dendrimers: an excellent drug carrier for improving the solubility and bioavailability of puerarin. Gu L; Wu Zh; Qi X; He H; Ma X; Chou X; Wen X; Zhang M; Jiao F Pharm Dev Technol; 2013; 18(5):1051-7. PubMed ID: 22303809 [TBL] [Abstract][Full Text] [Related]
48. [Comparative action of 8 azole derivatives against Candida albicans: fungistatic action and cytologic study by scanning electron microscopy]. Mallie M; Jouvert S; Bastide M; Montes B; Lebecq JC; Bastide JM Pathol Biol (Paris); 1988 May; 36(5):575-80. PubMed ID: 3043361 [TBL] [Abstract][Full Text] [Related]
49. Piperazine-Modified Ketoconazole Derivatives Show Increased Activity against Fungal and Trypanosomatid Pathogens. Štěpánek O; Čmoková A; Procházková E; Grobárová V; Černý J; Slapničková M; Zíková A; Kolařík M; Baszczyňski O ChemMedChem; 2022 Nov; 17(21):e202200385. PubMed ID: 36115047 [TBL] [Abstract][Full Text] [Related]
50. Effect of polyamidoamine (PAMAM) dendrimers on the in vitro release of water-insoluble nifedipine from aqueous gels. Devarakonda B; Li N; de Villiers MM AAPS PharmSciTech; 2005 Oct; 6(3):E504-12. PubMed ID: 16354011 [TBL] [Abstract][Full Text] [Related]
51. The influence of PAMAM dendrimers surface groups on their interaction with porcine pepsin. Ciolkowski M; Rozanek M; Bryszewska M; Klajnert B Biochim Biophys Acta; 2013 Oct; 1834(10):1982-7. PubMed ID: 23851144 [TBL] [Abstract][Full Text] [Related]
52. Effects of the association of antifungal drugs on the antimicrobial action of endodontic sealers. Weckwerth PH; Lima FL; Greatti VR; Duarte MA; Vivan RR Braz Oral Res; 2015; 29():. PubMed ID: 26083088 [TBL] [Abstract][Full Text] [Related]
53. Polypropyleneimine and polyamidoamine dendrimer mediated enhanced solubilization of bortezomib: Comparison and evaluation of mechanistic aspects by thermodynamics and molecular simulations. Chaudhary S; Gothwal A; Khan I; Srivastava S; Malik R; Gupta U Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():611-619. PubMed ID: 28024628 [TBL] [Abstract][Full Text] [Related]
54. NO-donors. Part 17: Synthesis and antimicrobial activity of novel ketoconazole-NO-donor hybrid compounds. Konter J; Möllmann U; Lehmann J Bioorg Med Chem; 2008 Sep; 16(17):8294-300. PubMed ID: 18710813 [TBL] [Abstract][Full Text] [Related]
56. Ketoconazole- Martin F; Pop M; Kacso I; Grosu IG; Miclăuş M; Vodnar D; Lung I; Filip GA; Olteanu ED; Moldovan R; Nagy A; Filip X; Bâldea I Mol Pharm; 2020 Mar; 17(3):919-932. PubMed ID: 31986050 [TBL] [Abstract][Full Text] [Related]
57. PEGylated PAMAM dendrimers: Enhancing efficacy and mitigating toxicity for effective anticancer drug and gene delivery. Luong D; Kesharwani P; Deshmukh R; Mohd Amin MCI; Gupta U; Greish K; Iyer AK Acta Biomater; 2016 Oct; 43():14-29. PubMed ID: 27422195 [TBL] [Abstract][Full Text] [Related]
58. Polyamidoamine Dendrimers for Enhanced Solubility of Small Molecules and Other Desirable Properties for Site Specific Delivery: Insights from Experimental and Computational Studies. Shadrack DM; Swai HS; Munissi JJE; Mubofu EB; Nyandoro SS Molecules; 2018 Jun; 23(6):. PubMed ID: 29895742 [TBL] [Abstract][Full Text] [Related]
59. Preparation and in vitro characterization of pluronic-attached polyamidoamine dendrimers for drug delivery. Gu Z; Wang M; Fang Q; Zheng H; Wu F; Lin D; Xu Y; Jin Y Drug Dev Ind Pharm; 2015 May; 41(5):812-8. PubMed ID: 24745851 [TBL] [Abstract][Full Text] [Related]
60. Ketoconazole and fluconazole inhibition of the metabolism of cyclosporin A by human liver in vitro. Omar G; Whiting PH; Hawksworth GM; Humphrey MJ; Burke MD Ther Drug Monit; 1997 Aug; 19(4):436-45. PubMed ID: 9263386 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]